Stocks › CDXS
CODEXIS, INC.
CDXS·Nasdaq·
United States·USD
United States·USD$1.36
-0.03 (-2.16%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CDXS
CODEXIS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CDXSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CDXS by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Lamar SmithHouse · R · TX |
CDXSCODEXIS, INC. · Stock |
Purchase $1,001 - $15,000 |
May 8, 2018 | Apr 6, 2018 | Filing ↗ |
Whale Activity
Position changes in CDXS reported for 2026-06-30 by 8 tracked institutional filers
- Increased5
- New0
- Held0
- Decreased3
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 7.3M | $16.5M | increased |
| MILLENNIUM MANAGEMENT LLC | 5.5M | $12.5M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | $8.2M | decreased |
| D. E. Shaw & Co., Inc. | 1.3M | $3.0M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $3.0M | increased |
| TWO SIGMA INVESTMENTS, LP | 696.6K | $1.6M | increased |
| CITADEL ADVISORS LLC | 191.6K | $433K | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 41.5K | $94K | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CDXS insiders, by quarter · Form 4
Recent Insider Transactions
643 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| De Vre RaymondDirector | Sale | −2,605 | $2.37 | $6K | Jun 11, 2026 | Form 4 ↗ |
| Lutz StefanChief Scientific Officer | Sale | −5,862 | $1.13 | $7K | Feb 24, 2026 | Form 4 ↗ |
| Lutz StefanChief Scientific Officer | Sale | −2,492 | $1.31 | $3K | Feb 6, 2026 | Form 4 ↗ |
| Erbez GeorgiaSee Remarks | Sale | −3,826 | $1.31 | $5K | Feb 6, 2026 | Form 4 ↗ |
| MOORE ALISONPresident and CEO · Director | Sale | −3,826 | $1.31 | $5K | Feb 6, 2026 | Form 4 ↗ |
| Lutz StefanCSO | Sale | −4,685 | $1.70 | $8K | Jan 7, 2026 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale Amended | −8,533 | $1.67 | $14K | Dec 1, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale Amended | −245.0K | $1.67 | $409K | Dec 1, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale | −8,533 | $1.67 | $14K | Dec 1, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale | −245.0K | $1.67 | $409K | Dec 1, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale Amended | −2,490 | $1.75 | $4K | Nov 28, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale Amended | −105.0K | $1.75 | $184K | Nov 28, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale | −2,490 | $1.75 | $4K | Nov 28, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale | −105.0K | $1.75 | $184K | Nov 28, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale Amended | −5,000 | $1.74 | $9K | Nov 26, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale Amended | −148.3K | $1.74 | $258K | Nov 26, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale | −5,000 | $1.74 | $9K | Nov 26, 2025 | Form 4 ↗ |
| Opaleye Management Inc.10% owner | Sale | +148.3K | $1.74 | $258K | Nov 26, 2025 | Form 4 ↗ |
| WOLF DENNIS PDirector | Sale | −8,952 | $1.56 | $14K | Nov 21, 2025 | Form 4 ↗ |
| MOORE ALISONPresident and CEO | Grant / award | +85.0K | $0.00 | $0 | Nov 13, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CDXS · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| abrdn Healthcare Investors | 4.4M | $10.0M | 0.74% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.6M | $6.0M | 0.00% | Jun 30, 2026 |
| abrdn Life Sciences Investors | 2.3M | $5.3M | 0.77% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 2.3M | $5.2M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund COLUMBIA FUNDS SERIES TRUST I | 2.7M | $3.7M | 0.15% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 895.9K | $2.0M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 696.1K | $1.6M | 0.01% | Jun 30, 2026 |
| Putnam Small Cap Value Fund Putnam Investment Funds | 492.7K | $1.4M | 0.46% | May 31, 2026 |
| iShares Biotechnology ETF iShares Trust | 593.7K | $1.3M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 942.5K | $1.3M | 0.00% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list CDXS's shares (CUSIP 192005106), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- LYTTON LAURENCE WSCHEDULE 13G/A · passive (13G) · 5.6M shares5.2%
Aug 13, 2026 · ↗ - Colin S. McNaySCHEDULE 13G · passive (13G) · 7.8M shares7.3%
Jul 29, 2026 · ↗ - Telemark Fund LPSCHEDULE 13G · passive (13G) · 7.8M shares7.3%
Jul 29, 2026 · ↗ - Telemark Asset Management, LLCSCHEDULE 13G · passive (13G) · 7.8M shares7.3%
Jul 29, 2026 · ↗ - abrdn Inc.SCHEDULE 13G/A · passive (13G) · 0 shares7.5%
Jul 20, 2026 · ↗ - Aberdeen Group plcSCHEDULE 13G/A · passive (13G) · 6.8M shares7.5%
Jul 20, 2026 · ↗ - James SilvermanSCHEDULE 13G/A · passive (13G) · 6.8M shares7.5%
May 5, 2026 · ↗ - Opaleye, L.P.SCHEDULE 13G/A · passive (13G) · 6.7M shares7.3%
May 5, 2026 · ↗ - Opaleye Management Inc.SCHEDULE 13G/A · passive (13G) · 6.8M shares7.5%
May 5, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CODEXIS, INC. as client
No lobbying filings found naming CODEXIS, INC. as the client.
Government Contracts
Federal awards to CODEXIS, INC. · USAspending
No federal contract awards found for CODEXIS, INC..
U.S. Patents
Recent USPTO applications naming CODEXIS, INC.
No USPTO patent applications found for CODEXIS, INC..
Annual Financials
From CDXS's 10-K filings · XBRL
No annual XBRL figures on record for CDXS. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CDXS's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsAug 11, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJul 27, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01Results of operations · Other eventsJul 23, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 22, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About CODEXIS, INC.
From SEC EDGAR company records
Industry (SIC 2860)Industrial Organic Chemicals
SectorMaterials
HeadquartersREDWOOD CITY, CA
IncorporatedDE
SEC CIK0001200375 ↗
Former namesCODEXIS INC